These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3840172)
21. Quantitation of a new hypoglycaemic drug, 2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate (DG-5128), in plasma by gas chromatography-mass spectrometry. Nakaoka M; Ohtani A; Hakusui H J Chromatogr; 1986 Jun; 378(2):467-72. PubMed ID: 3734003 [No Abstract] [Full Text] [Related]
22. A sensitive high-performance liquid chromatographic determination of 6-(pyridin-3-yl)-quinolin-2(1H)-one and its N-oxide metabolite in rat plasma and urine. On NT; Damani LA; Rance DJ J Pharm Biomed Anal; 1993; 11(4-5):421-5. PubMed ID: 8395223 [No Abstract] [Full Text] [Related]
23. Action of AR-L 115 BS on myocardial oxygen consumption, cardiac performance and vascular resistance and capacitance. Dämmgen J; Kadatz R; Diederen W Arzneimittelforschung; 1981; 31(1a):151-4. PubMed ID: 7195209 [TBL] [Abstract][Full Text] [Related]
24. High-performance liquid chromatographic method for the determination of adibendan in plasma and urine. Reiff K J Chromatogr; 1987 Nov; 422():346-52. PubMed ID: 3437024 [No Abstract] [Full Text] [Related]
26. Determination of denopamine in human and dog plasma by high-performance liquid chromatography with electrochemical detection. Tagawa K; Ueki T; Mizobe M; Noda K; Samejima M J Chromatogr; 1990 Aug; 529(2):500-6. PubMed ID: 2229268 [No Abstract] [Full Text] [Related]
27. [Calcium transport in sarcoplasmic reticulum in the presence of AR-L 115 BS]. Hasselbach W Arzneimittelforschung; 1981; 31(1a):191-3. PubMed ID: 7195219 [TBL] [Abstract][Full Text] [Related]
28. Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS. Kutter E; Austel V Arzneimittelforschung; 1981; 31(1a):135-41. PubMed ID: 7195206 [TBL] [Abstract][Full Text] [Related]
29. Effects of AR-L 115 BS, a new cardiotonic compound, on cardiac contractility, heart rate and blood pressure in anaesthetized and conscious animals. Diederen W; Kadatz R Arzneimittelforschung; 1981; 31(1a):146-50. PubMed ID: 7195208 [TBL] [Abstract][Full Text] [Related]
30. Analysis of 5-(4-acetamidophenyl)pyrazin-2(1H)-one (SK&F 94120) in plasma with an Analytichem automated sample processor liquid chromatography module. Pearce JC; Jelly JA; Fernandes KA; Leavens WJ; McDowall RD J Chromatogr; 1986 Feb; 353():371-8. PubMed ID: 3700521 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs. Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742 [TBL] [Abstract][Full Text] [Related]
32. Quantitation of 6-(pyridin-3-yl)quinolin-2(1H)-one, a cardiac stimulant, and its N-oxide metabolite in dog plasma by high-performance liquid chromatography. On NT; Damani LA; Rance DJ J Chromatogr; 1992 Feb; 574(2):352-5. PubMed ID: 1320044 [TBL] [Abstract][Full Text] [Related]
33. [Animal studies on the tolerability of AR-L 115 BS (author's transl)]. Schneider P; Bauer M; Eckenfels A; Lehmann H; Lützen L; Ueberberg H Arzneimittelforschung; 1981; 31(1a):226-32. PubMed ID: 7195227 [TBL] [Abstract][Full Text] [Related]
34. Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist. Stearns RA; Miller RR; Arison BH; Rosegay A; Smith JL; Mantlo NB; Chiu SH Drug Metab Dispos; 1993; 21(4):670-6. PubMed ID: 8104127 [TBL] [Abstract][Full Text] [Related]
35. High-performance liquid chromatographic procedure for the determination of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-(dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone, in human plasma and urine. Miyamoto G; Sasabe H; Odomi M; Shimizu T J Chromatogr; 1985 Mar; 338(2):450-5. PubMed ID: 3998030 [No Abstract] [Full Text] [Related]
37. Determination of the agonist-antagonist anxiolytic agent 6-(2-chlorophenyl)-4-hydroxy-4H-imidazo[1,5-a]-[1,4]benzodiazepine- 3-carboxamide and its benzophenone carboxylic acid metabolite in plasma by high-performance liquid chromatography. Puglisi CV; Ferrara FJ; Bekersky I J Chromatogr; 1987 Jul; 417(2):347-56. PubMed ID: 2888780 [TBL] [Abstract][Full Text] [Related]
38. Effect of sulmazole and pimobendan on contractility of skinned fibres from frog skeletal muscle. Piazzesi G; Morano I; Rüegg JC Arzneimittelforschung; 1987 Oct; 37(10):1141-3. PubMed ID: 3435586 [TBL] [Abstract][Full Text] [Related]
39. Assessment of the biotransformation of the cardiotonic agent piroximone by high-performance liquid chromatography and gas chromatography-mass spectrometry. Berg-Candolfi M; Borlakoglu JT; Dulery B; Jehl F; Haegele KD J Chromatogr; 1992 Feb; 593(1-2):1-7. PubMed ID: 1639892 [TBL] [Abstract][Full Text] [Related]
40. Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates. Kitani M; Miyamoto G; Nagasawa M; Yamada T; Matsubara J; Uchida M; Odomi M Drug Metab Dispos; 1997 Jun; 25(6):663-74. PubMed ID: 9193867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]